A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis

The outcome of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is only favorable in ≈ 40% of acute ischemic stroke (AIS) patients. Moreover, in ≈ 6–8% of cases, intracerebral hemorrhage (ICH) develops. We tested whether a modification of clot lysis assay (CLA), might...

Descripción completa

Detalles Bibliográficos
Autores principales: Orbán-Kálmándi, Rita, Szegedi, István, Sarkady, Ferenc, Fekete, István, Fekete, Klára, Vasas, Nikolett, Berényi, Ervin, Csiba, László, Bagoly, Zsuzsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208992/
https://www.ncbi.nlm.nih.gov/pubmed/34135389
http://dx.doi.org/10.1038/s41598-021-92041-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208992/
https://www.ncbi.nlm.nih.gov/pubmed/34135389
http://dx.doi.org/10.1038/s41598-021-92041-1

Ejemplares similares